Unlocking mRNA-Based Therapeutics: All Key Data in One Measurement with NanoFCM

Over the recent years, LNPs have paved new possibilities in the world of nanomedicine. From early stage research to clinical manufacturing, having accurate and comprehensive characterisation of LNPs is essential to assess their quality, consistency, and functionality. 

Conventional analytical tools such as dynamic light scattering (DLS) and Ribogreen assays provide valuable insights, but their limitations often require multiple techniques to be combined to achieve a complete understanding of your LNPs. Time consuming and resource intensive.

With NanoFCM, you can achieve all necessary data all at once. Our technology enables high-resolution, particle-by-particle characterisation, delivering key parameters including size, concentration, and encapsulation efficiency in one measurement. 
In this seminar we will showcase how our NanoAnalyzer platform, and demonstrate how it enables rapid, accurate, and cost-effective LNP characterisation. 

We provide the deeper insights – whilst simplifying your workflows.

Learning Objectives:

• Understand the analytical challenges associated with characterising heterogeneous LNP formulations
• Compare conventional nanoparticle characterisation (DLS, RiboGreen) techniques with single-particle approaches
• Explore how the NanoAnalyser enables deeper insight into LNP size, concentration, and cargo distribution